The peptide shows potential in a number of applications outside of the GI tract, including in its promotion of healing, muscle growth and repair, and injury recovery
The arrival of oral semaglutide (Wegovy pill) approved in December 2025 may further improve adherence, as patients who are averse to injections gain a needle-free option ( [19] )
Anyone with personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2) should not use GLP-1 agonists
If the heart muscle is depleted of CoQ10 and L-carnitine, it cannot efficiently burn fatty acids to meet this heightened demand, exacerbating symptoms of severe tachycardia, chest pain, shortness of breath, and profound, whole-body exhaustion
A meta-analysis of 10 trials totaling 71,351 patients extended these findings, showing GLP-1 receptor agonists reduced the composite kidney outcome by 17% across trials